PTAB Grants Motion to Amend Claims, Kind Of, PTAB Litigation Blog
Visit the Jones Day PTAB Litigation Blog.
In Amerigen Pharmaceuticals Limited v. Shire LLC, IPR2015-02009 (March 31, 2017), the PTAB granted Shire’s Motion to Amend the claims in U.S. Reissued Patent RE 42,096, listed in the FDA’s Orange Book as covering Shire’s Adderall XR®.
Read the full article at ptablitigationblog.com.
